ATE22181T1 - Verfahren und mittel zur bestimmung des glucosegehaltes in blutproben. - Google Patents

Verfahren und mittel zur bestimmung des glucosegehaltes in blutproben.

Info

Publication number
ATE22181T1
ATE22181T1 AT82307051T AT82307051T ATE22181T1 AT E22181 T1 ATE22181 T1 AT E22181T1 AT 82307051 T AT82307051 T AT 82307051T AT 82307051 T AT82307051 T AT 82307051T AT E22181 T1 ATE22181 T1 AT E22181T1
Authority
AT
Austria
Prior art keywords
sample
colour
glucose
blood
colouring agent
Prior art date
Application number
AT82307051T
Other languages
English (en)
Inventor
John Richard Baker
Original Assignee
John Richard Baker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Richard Baker filed Critical John Richard Baker
Application granted granted Critical
Publication of ATE22181T1 publication Critical patent/ATE22181T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/904—Oxidation - reduction indicators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104998—Glucose, ketone, nitrate standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y10T436/144444—Glucose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT82307051T 1981-12-23 1982-12-22 Verfahren und mittel zur bestimmung des glucosegehaltes in blutproben. ATE22181T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ199380A NZ199380A (en) 1981-12-23 1981-12-23 Determination of serum glucose levels in blood samples
EP82307051A EP0085263B1 (de) 1981-12-23 1982-12-22 Verfahren und Mittel zur Bestimmung des Glucosegehaltes in Blutproben

Publications (1)

Publication Number Publication Date
ATE22181T1 true ATE22181T1 (de) 1986-09-15

Family

ID=19919846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82307051T ATE22181T1 (de) 1981-12-23 1982-12-22 Verfahren und mittel zur bestimmung des glucosegehaltes in blutproben.

Country Status (12)

Country Link
US (2) US4642295A (de)
EP (1) EP0085263B1 (de)
JP (2) JPS58154660A (de)
AT (1) ATE22181T1 (de)
AU (1) AU554029B2 (de)
CA (1) CA1235050A (de)
DE (1) DE3273255D1 (de)
DK (1) DK158482C (de)
HK (1) HK16990A (de)
IN (1) IN156045B (de)
NZ (1) NZ199380A (de)
ZA (1) ZA829252B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60227171A (ja) * 1984-04-25 1985-11-12 Sogo Seibutsu Igaku Kenkyusho:Kk ヘモグロビンに結合したグルコ−スの測定方法
US5002893A (en) * 1985-09-19 1991-03-26 Isolab, Inc. Single color reading method for determining fructosamine
JPS62215398A (ja) * 1986-01-06 1987-09-22 アイソラブ，インク． 医療診断用指示要素として羊水中のホスフアチジルグリセロ−ルの量を測定する方法とそのキツト
DE3620817A1 (de) * 1986-06-21 1987-12-23 Boehringer Mannheim Gmbh Verfahren zur spezifischen bestimmung des serumfructosamingehalts sowie hierfuer geeignetes reagenzgemisch
DE3743405A1 (de) * 1987-05-14 1988-11-24 Boehringer Mannheim Gmbh Verfahren zur bestimmung von fructosamin
DE3822749A1 (de) * 1988-07-05 1990-01-11 Boehringer Mannheim Gmbh Fructosamin-calibrator
DE3824562A1 (de) * 1988-07-19 1990-02-01 Boehringer Mannheim Gmbh Verfahren zur bestimmung von fructosamin
US5132230A (en) * 1989-03-28 1992-07-21 Isolab, Inc. Primary standard and method of making secondary standards for calibration of glycated protein assays
US5110745A (en) * 1989-06-01 1992-05-05 The Trustees Of The University Of Pennsylvania Methods of detecting glycated proteins
US4956301A (en) * 1989-11-02 1990-09-11 Miles Inc. Test device and method of assaying for fructosamines
JP2796150B2 (ja) * 1989-12-20 1998-09-10 株式会社ヤトロン フルクトサミンの測定方法
JP2950592B2 (ja) * 1990-08-30 1999-09-20 株式会社京都第一科学 フルクトサミン測定用多層分析用具
US5565170A (en) * 1990-08-30 1996-10-15 Kyoto Daiichi Kagaku Co., Ltd. Multilayer analytical element for assaying fructosamine
US5571723A (en) * 1991-02-07 1996-11-05 Evans; Cody A. Method of testing for diabetes that reduces the effect of interfering substances
US5312760A (en) * 1992-06-08 1994-05-17 Modrovich, Ivan Endre Fructosamine reagent and calibrator system
DE69327242T2 (de) * 1992-07-02 2000-05-25 Roche Diagnostics Corp., Indianapolis Stabilisierung von tetrazoliumsalzen in einem reagenz
US5354658A (en) * 1993-01-28 1994-10-11 Dennis Wright Non-radioactive method for detecting a labelled segment and a solution or composition therefor
CA2127679A1 (en) * 1993-07-27 1995-01-28 Ewald Vorberg Set of reagents for determining the fructosamine content
US5470752A (en) * 1994-06-29 1995-11-28 Lxn Corporation Multi-layer devices and methods of assaying for fructosamine
US5695949A (en) * 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
US5712167A (en) * 1995-07-19 1998-01-27 Kyoto Dai-Ichi Kagaku Co., Ltd. Method of measuring Amadori compound by light scattering
US5639672A (en) * 1995-10-16 1997-06-17 Lxn Corporation Electrochemical determination of fructosamine
US5916746A (en) * 1996-05-09 1999-06-29 Kirkegaard & Perry Laboratories, Inc. Formazan-based immunoassay
US6225074B1 (en) 1997-08-18 2001-05-01 Dennis Wright Direct chloramphenicol acetyl transferase assay
US7494816B2 (en) 1997-12-22 2009-02-24 Roche Diagnostic Operations, Inc. System and method for determining a temperature during analyte measurement
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US7390667B2 (en) * 1997-12-22 2008-06-24 Roche Diagnostics Operations, Inc. System and method for analyte measurement using AC phase angle measurements
US7407811B2 (en) * 1997-12-22 2008-08-05 Roche Diagnostics Operations, Inc. System and method for analyte measurement using AC excitation
US7604721B2 (en) 2003-06-20 2009-10-20 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8148164B2 (en) * 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US7597793B2 (en) * 2003-06-20 2009-10-06 Roche Operations Ltd. System and method for analyte measurement employing maximum dosing time delay
US7452457B2 (en) * 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7645373B2 (en) * 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US8058077B2 (en) * 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US7645421B2 (en) * 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
WO2005078118A1 (en) 2004-02-06 2005-08-25 Bayer Healthcare Llc Oxidizable species as an internal reference for biosensors and method of use
US7556723B2 (en) * 2004-06-18 2009-07-07 Roche Diagnostics Operations, Inc. Electrode design for biosensor
US7569126B2 (en) 2004-06-18 2009-08-04 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
EP1913374B1 (de) 2005-07-20 2019-01-09 Ascensia Diabetes Care Holdings AG Verfahren zur signalisierung des benutzers zum hinzufügen einer zusätzlichen probe zu einem prüfstreifen, verfahren zum messen der temperatur einer probe und verfahren zur bestimmung der konzentration eines analyten auf basis von puls-amperometrie
RU2426107C2 (ru) 2005-09-30 2011-08-10 БАЙЕР ХЕЛТКЭА ЭлЭлСи Вольтамперометрический способ определения концентрации аналита в образце и устройство для определения концентрации аналита
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
US20120077278A1 (en) * 2009-06-08 2012-03-29 Protea Biopharma N.V. Methods and kits for detecting, diagnosing and monitoring diseases
US20190263888A1 (en) 2010-10-19 2019-08-29 Op-T Llc Therapeutic peptides and methods for treating autoimmune related disease
US11793854B2 (en) 2019-03-21 2023-10-24 Op-T Llc Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction
US11744875B2 (en) 2019-07-12 2023-09-05 Op-T Llc Peptides and methods for treating disease
EP4135742A2 (de) 2020-04-17 2023-02-22 Op-T Llc Bioaktive peptide und verfahren zur verwendung davon

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1135880A (fr) * 1954-08-24 1957-05-06 Procédé de détermination de l'ovulation
US2981606A (en) * 1955-06-20 1961-04-25 Lilly Co Eli Glucose indicator and method
US3653841A (en) * 1969-12-19 1972-04-04 Hoffmann La Roche Methods and compositions for determining glucose in blood
US3682586A (en) * 1971-03-10 1972-08-08 Union Carbide Corp Process for the determination of creatinine body fluids
US3791988A (en) * 1972-03-23 1974-02-12 Hoffmann La Roche Diagnostic test for glucose
US3920580A (en) * 1973-07-12 1975-11-18 Miles Lab Liquid control solution
US4269605A (en) * 1978-06-28 1981-05-26 Amicon Corporation Method and kit for separation of glycoproteins
US4200435A (en) * 1978-12-26 1980-04-29 Abbott Laboratories Determination of glycosylated hemoglobin in blood
US4243534A (en) * 1979-01-25 1981-01-06 Becton, Dickinson And Company Blood separation
US4268270A (en) * 1979-04-30 1981-05-19 Children's Hospital Medical Center Glycosylated hemoglobin measurement
US4260516A (en) * 1979-12-07 1981-04-07 Abbott Laboratories Glycosylated hemoglobin standards
US4371374A (en) * 1980-11-17 1983-02-01 The Rockefeller University Monitoring metabolic control in diabetic patients by measuring glycosylated amino acids and peptides in urine
US4407961A (en) * 1981-03-16 1983-10-04 Sanders James L Ion-exchange system and method for isolation and determination of glycosylated hemoglobin in human blood
DE3119046C2 (de) * 1981-05-13 1983-03-10 Panchem Gesellschaft für chemische Produkte mbH, 8751 Kleinwallstadt Verfahren zur Bestimmung des Gehalts an glykosiliertem Hämoglobin bei der Langzeitkontrolle des Blutzuckerspiegels
US4409335A (en) * 1982-05-28 1983-10-11 Bio-Rad Laboratories, Inc. Method for eliminating glucose dependent Schiff base effect from hemoglobin A1 assay

Also Published As

Publication number Publication date
JPH02263163A (ja) 1990-10-25
IN156045B (de) 1985-04-27
CA1235050A (en) 1988-04-12
DK567782A (da) 1983-06-24
US4642295A (en) 1987-02-10
NZ199380A (en) 1986-08-08
EP0085263A1 (de) 1983-08-10
DE3273255D1 (en) 1986-10-16
AU554029B2 (en) 1986-08-07
US4645742A (en) 1987-02-24
AU9162682A (en) 1983-06-30
HK16990A (en) 1990-03-09
ZA829252B (en) 1984-01-25
DK158482C (da) 1990-10-15
JPS58154660A (ja) 1983-09-14
EP0085263B1 (de) 1986-09-10
DK158482B (da) 1990-05-21
JPH0113062B2 (de) 1989-03-03

Similar Documents

Publication Publication Date Title
ATE22181T1 (de) Verfahren und mittel zur bestimmung des glucosegehaltes in blutproben.
Hillier The quantitative measurement of whey proteins using polyacrylamide-gel electrophoresis
YU46053B (sh) Postopek za specifično določanje vsebnosti serumskega fruktozamina
HUP9901321A2 (hu) Eljárások és készítmények nukleinsav-molekulák szekvenciájának maghatározására
SE7902734L (sv) Forfarande och apparat for analys av blod
DK622688A (da) Analysemetode og testsystem til bestemmelse af en analyt i en blodproeve
DE3586075D1 (de) Verfahren zur bestimmung von endotoxin.
EP0033960A3 (de) Verfahren zur Vorbehandlung von Proben, welche für die Bestimmung von carcinoembryonischem Antigen verwendet werden
FI925781A0 (fi) Analys av analytvarianter
ATE64784T1 (de) Einfarbenablesendes verfahren zur bestimmung vom fructosamin.
DE3262693D1 (en) Method and composition for determining glycosylated hemoglobin
ATE74211T1 (de) Verfahren zum nachweis eines analyten sowie hierfuer geeignetes mittel.
ATE108025T1 (de) Menschliches igg glykosylation-bestimmung.
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
Swatditat et al. Determining simple sulfhydryl compounds (low molecular weight) and their contents in biological samples by using 2, 2′-dithiobis-(5-nitropyridine)
DE69026006D1 (de) Enzymatisches Verfahren zur Bestimmung der Analyt-Konzentration
DE3877493D1 (de) Verfahren und vorrichtung zur volumetrischen bestimmung, verduennung und uebertragung von fluessigkeitsproben.
ATE216494T1 (de) Methode zum nachweis von fructosamin
Berger et al. Protein and enzyme polymorphisms in human semen
Bonte et al. Experimental investigations in post-mortal protein degradation
FI99027B (fi) Menetelmä kliinisen näytteen riittävyyden määrittämiseksi
Larson et al. Evaluation of milk protein synthesis
UA16793A1 (uk) СПОСІБ ВИЗHАЧЕHHЯ РАДІОАКТИВHОГО СТРОHЦІЮ Sr-90 В МОЛОЦІ
JPS5270017A (en) Novel method for immono-assay
GEP19991556B (en) Method for Determining of Copper in Milk

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time